Market Indices
Sector Heatmap
INCY — Incyte Genomics Inc
NasdaqIncyte Genomics Inc
- O
- 115.15
- H
- 115.67
- L
- 112.83
- V
- 1.94M
INCY — Latest News & Headlines
20 StoriesIncyte (INCY) Stock Could Be 34% Above Fair Value After EADV Data - Yahoo Finance
Incyte (INCY) Stock Could Be 34% Above Fair Value After EADV Data Yahoo Finance
Incyte (INCY) Stock Could Be 33% Overvalued After Fresh EADV Data - Simply Wall Street
Incyte (INCY) Stock Could Be 33% Overvalued After Fresh EADV Data Simply Wall Street
Incyte Stock Price Forecast. Should You Buy INCY? - StockInvest.us
Incyte Stock Price Forecast. Should You Buy INCY? StockInvest.us
A legal chief with more than 25 years in pharma and biotech joins MiniMed. - Stock Titan
A legal chief with more than 25 years in pharma and biotech joins MiniMed. Stock Titan
Incyte (NASDAQ:INCY) Combines High Growth Momentum With a Breakout Setup - ChartMill
Incyte (NASDAQ:INCY) Combines High Growth Momentum With a Breakout Setup ChartMill
If You Invested $1000 In Incyte Stock 20 Years Ago, You Would Have This Much Today - Benzinga
If You Invested $1000 In Incyte Stock 20 Years Ago, You Would Have This Much Today Benzinga
INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill - stocktwits.com
INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill stocktwits.com
INCY Maintained by HC Wainwright & Co. -- Price Target Raised to $152 - GuruFocus
INCY Maintained by HC Wainwright & Co. -- Price Target Raised to $152 GuruFocus
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks? - Yahoo Finance
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks? Yahoo Finance
Incyte will present research on eczema, vitiligo and painful skin conditions in Vienna - Stock Titan
Incyte will present research on eczema, vitiligo and painful skin conditions in Vienna Stock Titan
INCY or TECH: Which Is the Better Value Stock Right Now? - Yahoo Finance
INCY or TECH: Which Is the Better Value Stock Right Now? Yahoo Finance
Incyte (INCY) withheld shares from its strategy chief for taxes at a reported $126.93 per share. - Stock Titan
Incyte (INCY) withheld shares from its strategy chief for taxes at a reported $126.93 per share. Stock Titan
A $40,500 director retainer becomes 322 shares for Julian C. Baker at Incyte (INCY). - Stock Titan
A $40,500 director retainer becomes 322 shares for Julian C. Baker at Incyte (INCY). Stock Titan
Incyte (INCY) Heads To EADV With New Skin Disease Trial Data - Yahoo Finance
Incyte (INCY) Heads To EADV With New Skin Disease Trial Data Yahoo Finance
203 shares replace director fees at Incyte (INCY), with the award fully vested. - Stock Titan
203 shares replace director fees at Incyte (INCY), with the award fully vested. Stock Titan
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment - Yahoo Finance
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment Yahoo Finance
About 300 people in the U.S. have a disease that causes bone to form in soft tissues. FDA approves a treatment. - Stock Titan
About 300 people in the U.S. have a disease that causes bone to form in soft tissues. FDA approves a treatment. Stock Titan
Shares replace quarterly director fees as Incyte (INCY) awards 206 fully vested shares. - Stock Titan
Shares replace quarterly director fees as Incyte (INCY) awards 206 fully vested shares. Stock Titan
463 shares are automatically withheld for taxes from Incyte (INCY) EVP Lee Heeson at $117.14 each. - Stock Titan
463 shares are automatically withheld for taxes from Incyte (INCY) EVP Lee Heeson at $117.14 each. Stock Titan
Incyte (INCY), What Is Behind The Fresh Attention? - Simply Wall Street
Incyte (INCY), What Is Behind The Fresh Attention? Simply Wall Street